{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:54:51Z","timestamp":1791831291482,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,10,11]],"date-time":"2015-10-11T00:00:00Z","timestamp":1444521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00330-015-3982-y","type":"journal-article","created":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T16:26:38Z","timestamp":1444667198000},"page":"1640-1648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Guillaume","family":"Vesselle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Quirier-Leleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Charier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Silvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Boucebci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ingrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Tasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,11]]},"reference":[{"key":"3982_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","volume":"33","author":"J Lammer","year":"2010","unstructured":"Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A et al (2010) Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study. Cardiovasc Intervent Radiol 33:41\u201352","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3982_CR2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00270-009-9750-0","volume":"33","author":"K Malagari","year":"2010","unstructured":"Malagari K, Pomoni M, Kelekis A et al (2010) Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 33:541\u201351","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3982_CR3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jhep.2012.07.017","volume":"57","author":"MJ Song","year":"2012","unstructured":"Song MJ, Chun HJ, Song DS et al (2012) Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol 57:1244\u201350","journal-title":"J Hepatol"},{"key":"3982_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Varela","year":"2007","unstructured":"Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474\u201381","journal-title":"J Hepatol"},{"key":"3982_CR5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.RVI.0000195323.46152.B3","volume":"17","author":"AL Lewis","year":"2006","unstructured":"Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC Bead: In Vitro Characterization of a Drug-delivery Device for Transarterial Chemoembolization. J Vasc Interv Radiol 17:335\u201342","journal-title":"J Vasc Interv Radiol"},{"key":"3982_CR6","doi-asserted-by":"crossref","unstructured":"Kettenbach J, Stadler A, Katzler IV et al (2008) Drug-Loaded Microspheres for the Treatment of Liver Cancer: Review of Current Results. Cardiovasc Intervent Radiol 31:468\u201376","DOI":"10.1007\/s00270-007-9280-6"},{"key":"3982_CR7","doi-asserted-by":"crossref","unstructured":"Huang K, Zhou Q, Wang R, Cheng D, Ma Y (2014) Doxorubicin-eluting Bead versus Conventional Transarterial Chemoembolization for the Treatment of HCC: a Meta-Analysis. J Gastroenterol Hepatol 29(5):920\u2013925","DOI":"10.1111\/jgh.12439"},{"key":"3982_CR8","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer","year":"2012","unstructured":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL\u2013EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 56:908\u201343","journal-title":"J Hepatol"},{"key":"3982_CR9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: An update. Hepatology 53:1020\u20132","journal-title":"Hepatology"},{"key":"3982_CR10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ctrv.2010.07.006","volume":"37","author":"J-L Raoul","year":"2011","unstructured":"Raoul J-L, Sangro B, Forner A et al (2011) Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 37:212\u201320","journal-title":"Cancer Treat Rev"},{"key":"3982_CR11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0032-1329906","volume":"32","author":"L Bolondi","year":"2013","unstructured":"Bolondi L, Burroughs A, Dufour J-F et al (2013) Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions. Semin Liver Dis 32:348\u201359","journal-title":"Semin Liver Dis"},{"key":"3982_CR12","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1245\/s10434-011-1551-4","volume":"18","author":"D D\u2019Avola","year":"2011","unstructured":"D\u2019Avola D, I\u00f1arrairaegui M, Pardo F et al (2011) Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages. Ann Surg Oncol 18:1964\u201371","journal-title":"Ann Surg Oncol"},{"key":"3982_CR13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.gastro.2011.04.054","volume":"141","author":"K Memon","year":"2011","unstructured":"Memon K, Kulik L, Lewandowski RJ et al (2011) Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology 141:526\u201335, 535.e1\u20132","journal-title":"Gastroenterology"},{"key":"3982_CR14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2036.2012.05089.x","volume":"35","author":"DY Kim","year":"2012","unstructured":"Kim DY, Ryu HJ, Choi JY et al (2012) Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. Aliment Pharmacol Ther 35:1343\u201350","journal-title":"Aliment Pharmacol Ther"},{"key":"3982_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1148\/radiol.12112264","volume":"265","author":"C Georgiades","year":"2012","unstructured":"Georgiades C, Geschwind J-F, Harrison N et al (2012) Lack of Response after Initial Chemoembolization for Hepatocellular Carcinoma: Does It Predict Failure of Subsequent Treatment? Radiology 265:115\u201323","journal-title":"Radiology"},{"key":"3982_CR16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2014.01.014","volume":"60","author":"J Choi","year":"2014","unstructured":"Choi J, Shim JH, Shin YM, Kim KM, Lim Y-S, Lee HC (2014) Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol 60:1212\u20138","journal-title":"J Hepatol"},{"key":"3982_CR17","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jhep.2011.11.020","volume":"56","author":"K Memon","year":"2012","unstructured":"Memon K, Kulik L, Lewandowski RJ et al (2012) Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis. J Hepatol 56:1112\u201320","journal-title":"J Hepatol"},{"key":"3982_CR18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/annonc\/mds605","volume":"24","author":"HJ Prajapati","year":"2013","unstructured":"Prajapati HJ, Spivey JR, Hanish SI et al (2013) mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE). Ann Oncol 24:965\u201373","journal-title":"Ann Oncol"},{"key":"3982_CR19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00270-012-0394-0","volume":"35","author":"K Malagari","year":"2012","unstructured":"Malagari K, Pomoni M, Moschouris H et al (2012) Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis. Cardiovasc Intervent Radiol 35:1119\u201328","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3982_CR20","doi-asserted-by":"crossref","unstructured":"Odisio BC, Galastri F, Avritscher R et al. (2014) Hepatocellular Carcinomas within the Milan Criteria: Predictors of Histologic Necrosis after Drug-eluting Beads Transarterial Chemoembolization. Cardiovasc Intervent Radiol\u00a037(4):1018-1026","DOI":"10.1007\/s00270-013-0759-z"},{"key":"3982_CR21","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/hep.24246","volume":"53","author":"R Golfieri","year":"2011","unstructured":"Golfieri R, Cappelli A, Cucchetti A et al (2011) Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas. Hepatology 53:1580\u20139","journal-title":"Hepatology"},{"key":"3982_CR22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/lt.23413","volume":"18","author":"SW Kwan","year":"2012","unstructured":"Kwan SW, Fidelman N, Ma E, Kerlan RK, Yao FY (2012) Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation. Liver Transplant 18:727\u201336","journal-title":"Liver Transplant"},{"key":"3982_CR23","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00270-009-9766-5","volume":"33","author":"A Riaz","year":"2010","unstructured":"Riaz A, Lewandowski RJ, Kulik L et al (2010) Radiologic\u2013Pathologic Correlation of Hepatocellular Carcinoma Treated with Chemoembolization. Cardiovasc Intervent Radiol 33:1143\u201352","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3982_CR24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/hpb.12149","volume":"16","author":"MK Bryant","year":"2014","unstructured":"Bryant MK, Dorn DP, Zarzour J et al (2014) Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization. HPB 16:327\u201335","journal-title":"HPB"},{"key":"3982_CR25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1245\/s10434-009-0788-7","volume":"17","author":"JH Shim","year":"2010","unstructured":"Shim JH, Kim KM, Lee Y-J et al (2010) Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection. Ann Surg Oncol 17:869\u201377","journal-title":"Ann Surg Oncol"},{"key":"3982_CR26","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.ejrad.2011.05.004","volume":"81","author":"M-Y Lee","year":"2012","unstructured":"Lee M-Y, Chuang VP, Wei C-J, Cheng T-Y, Cherng M-T (2012) Histopathologic correlation of hepatocellular carcinoma after transcatheter arterial chemoembolization with polyvinyl alcohol particle of various sizes. Eur J Radiol 81:1976\u20139","journal-title":"Eur J Radiol"},{"key":"3982_CR27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jvir.2011.03.005","volume":"22","author":"HT Hu","year":"2011","unstructured":"Hu HT, Kim JH, Lee L-S et al (2011) Chemoembolization for Hepatocellular Carcinoma: Multivariate Analysis of Predicting Factors for Tumor Response and Survival in a 362-Patient Cohort. J Vasc Interv Radiol 22:917\u201323","journal-title":"J Vasc Interv Radiol"},{"key":"3982_CR28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00330-014-3099-8","volume":"24","author":"K Hayakawa","year":"2014","unstructured":"Hayakawa K, Tanikake M, Kirishima T, Yoshinami N, Shintani H, Yamamoto E et al (2014) The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC). Eur Radiol 24:1105\u201311","journal-title":"Eur Radiol"},{"key":"3982_CR29","doi-asserted-by":"crossref","first-page":"052","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet J (2010) Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. Semin Liver Dis 30:052\u201360","journal-title":"Semin Liver Dis"},{"key":"3982_CR30","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jhep.2011.03.007","volume":"55","author":"R Gillmore","year":"2011","unstructured":"Gillmore R, Stuart S, Kirkwood A et al (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol 55:1309\u201316","journal-title":"J Hepatol"},{"key":"3982_CR31","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s00270-010-0036-3","volume":"34","author":"S Miyayama","year":"2011","unstructured":"Miyayama S, Yamashiro M, Hattori Y et al (2011) Angiographic evaluation of feeding arteries of hepatocellular carcinoma in the caudate lobe of the liver. Cardiovasc Intervent Radiol 34:1244\u201353","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3982_CR32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1148\/94.3.575","volume":"94","author":"HC Redman","year":"1970","unstructured":"Redman HC, Reuter SR (1970) Arterial Collaterals in the Liver Hilus. Radiology 94:575\u20139","journal-title":"Radiology"},{"key":"3982_CR33","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jvir.2011.06.007","volume":"22","author":"MHK Abdelmaksoud","year":"2011","unstructured":"Abdelmaksoud MHK, Louie JD, Kothary N et al (2011) Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization. J Vasc Interv Radiol 22:1355\u201362","journal-title":"J Vasc Interv Radiol"},{"key":"3982_CR34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1148\/radiol.2371040919","volume":"237","author":"T Tohma","year":"2005","unstructured":"Tohma T, Cho A, Okazumi S et al (2005) Communicating arcade between the right and left hepatic arteries: evaluation with CT and angiography during temporary balloon occlusion of the right or left hepatic artery. Radiology 237:361\u20135","journal-title":"Radiology"},{"key":"3982_CR35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1148\/radiol.12112316","volume":"266","author":"R Loffroy","year":"2013","unstructured":"Loffroy R, Lin M, Yenokyan G et al (2013) Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? Radiology 266:636\u201348","journal-title":"Radiology"},{"key":"3982_CR36","first-page":"1","volume":"20","author":"SJ Choi","year":"2015","unstructured":"Choi SJ, Kim J, Seo J, Kim HS, Lee J, Park H (2015) Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization. Eur Radiol 20:1\u201310","journal-title":"Eur Radiol"},{"key":"3982_CR37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/RCT.0000000000000070","volume":"38","author":"DM Yeo","year":"2014","unstructured":"Yeo DM, Choi J-I, Lee YJ, Park MY, Chun HJ, Lee HG (2014) Comparison of RECIST, mRECIST, and choi criteria for early response evaluation of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads. J Comput Assist Tomogr 38:391\u20137","journal-title":"J Comput Assist Tomogr"},{"key":"3982_CR38","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jvir.2007.06.028","volume":"18","author":"RJ Lewandowski","year":"2007","unstructured":"Lewandowski RJ, Wang D, Gehl J et al (2007) A Comparison of Chemoembolization Endpoints Using Angiographic versus Transcatheter Intraarterial Perfusion\/MR Imaging Monitoring. J Vasc Interv Radiol 18:1249\u201357","journal-title":"J Vasc Interv Radiol"},{"key":"3982_CR39","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/01.RVI.0000228416.21560.7F","volume":"17","author":"AL Lewis","year":"2006","unstructured":"Lewis AL, Taylor RR, Hall B, Gonzalez MV, Willis SL, Stratford PW (2006) Pharmacokinetic and Safety Study of Doxorubicin-eluting Beads in a Porcine Model of Hepatic Arterial Embolization. J Vasc Interv Radiol 17:1335\u201343","journal-title":"J Vasc Interv Radiol"},{"key":"3982_CR40","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jvir.2008.06.008","volume":"19","author":"K-H Lee","year":"2008","unstructured":"Lee K-H, Liapi E, Vossen JA et al (2008) Distribution of Iron Oxide\u2013containing Embosphere Particles after Transcatheter Arterial Embolization in an Animal Model of Liver Cancer: Evaluation with MR Imaging and Implication for Therapy. J Vasc Interv Radiol 19:1490\u20136","journal-title":"J Vasc Interv Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-015-3982-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-015-3982-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-015-3982-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:59:58Z","timestamp":1559030398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-015-3982-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3982"],"URL":"https:\/\/doi.org\/10.1007\/s00330-015-3982-y","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,11]]}}}